Literature DB >> 2821435

Potentiators of responses to activation of gamma-aminobutyric acid (GABAA) receptors.

M A Simmonds1, J P Turner.   

Abstract

Quantitative aspects of the potentiation of GABA and muscimol by benzodiazepines and barbiturates are reviewed, taking account of both electrophysiological and receptor binding data. It has been a consistent finding that barbiturates cause a greater maximal potentiation than do benzodiazepines. The steroid anaesthetic alphaxalone and some naturally occurring steroids were compared as potentiators of electrophysiological responses to muscimol. From the relative potencies, important structural features of the steroid molecule for this effect have been identified. The possibility of the barbiturates and the steroids having a common mode of action as potentiators of GABA and muscimol is discussed, together with the idea that this action may involve perturbation of membrane lipids rather than a barbiturate/steroid receptor site. The GABA-potentiating effect of ethanol may also be barbiturate-like but potentiations by chlormethiazole and ketamine appear to involve different mechanisms. It is predicted that any endogenous potentiators of GABA would be unlikely to have more than a modest effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821435     DOI: 10.1016/0028-3908(87)90071-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones.

Authors:  T G Hales; J J Lambert
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. Ireland, 6th-8th July, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

Review 4.  Nongenomic action of steroids in myometrial contractility.

Authors:  M Perusquía
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro. Indirect support for a "natural" benzodiazepine-like substance in the intestine.

Authors:  K Racké; H Schwörer; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

6.  The modulation by chlormethiazole of the GABAA-receptor complex in rat brain.

Authors:  A J Cross; J M Stirling; T N Robinson; D M Bowen; P T Francis; A R Green
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.

Authors:  A Jussofie; A Schmiz; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

8.  Functional changes in GABAA receptor stimulation during the oestrous cycle of the rat.

Authors:  P Westerling; S Lindgren; B Meyerson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil.

Authors:  A J Cross; J A Jones; H A Baldwin; A R Green
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 10.  Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies.

Authors:  H Steve White; Wolfgang Löscher
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.